Report Detail

Other Global Gene Delivery System Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4528739
  • |
  • 13 April, 2023
  • |
  • Global
  • |
  • 101 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
According to our (Global Info Research) latest study, the global Gene Delivery System market size was valued at USD 7282.5 million in 2022 and is forecast to a readjusted size of USD 37570 million by 2029 with a CAGR of 26.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.
North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.
Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.
This report is a detailed and comprehensive analysis for global Gene Delivery System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Gene Delivery System market size and forecasts, in consumption value ($ Million), 2018-2029
Global Gene Delivery System market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Gene Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Gene Delivery System market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Delivery System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Delivery System market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Gene Delivery System market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Market segment by Application
Neurological Diseases
Cancer
Others
Market segment by players, this report covers
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Delivery System, with revenue, gross margin and global market share of Gene Delivery System from 2018 to 2023.
Chapter 3, the Gene Delivery System competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene Delivery System market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Delivery System.
Chapter 13, to describe Gene Delivery System research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Gene Delivery System
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Gene Delivery System by Type
    • 1.3.1 Overview: Global Gene Delivery System Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Gene Delivery System Consumption Value Market Share by Type in 2022
    • 1.3.3 Viral Gene Delivery System
    • 1.3.4 Non-viral Gene Delivery System
  • 1.4 Global Gene Delivery System Market by Application
    • 1.4.1 Overview: Global Gene Delivery System Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Neurological Diseases
    • 1.4.3 Cancer
    • 1.4.4 Others
  • 1.5 Global Gene Delivery System Market Size & Forecast
  • 1.6 Global Gene Delivery System Market Size and Forecast by Region
    • 1.6.1 Global Gene Delivery System Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Gene Delivery System Market Size by Region, (2018-2029)
    • 1.6.3 North America Gene Delivery System Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Gene Delivery System Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Gene Delivery System Market Size and Prospect (2018-2029)
    • 1.6.6 South America Gene Delivery System Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Gene Delivery System Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Biogen
    • 2.1.1 Biogen Details
    • 2.1.2 Biogen Major Business
    • 2.1.3 Biogen Gene Delivery System Product and Solutions
    • 2.1.4 Biogen Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Biogen Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Gene Delivery System Product and Solutions
    • 2.2.4 Novartis Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Gilead Sciences
    • 2.3.1 Gilead Sciences Details
    • 2.3.2 Gilead Sciences Major Business
    • 2.3.3 Gilead Sciences Gene Delivery System Product and Solutions
    • 2.3.4 Gilead Sciences Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Gilead Sciences Recent Developments and Future Plans
  • 2.4 Sarepta Therapeutics
    • 2.4.1 Sarepta Therapeutics Details
    • 2.4.2 Sarepta Therapeutics Major Business
    • 2.4.3 Sarepta Therapeutics Gene Delivery System Product and Solutions
    • 2.4.4 Sarepta Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
  • 2.5 Alnylam Pharmaceuticals
    • 2.5.1 Alnylam Pharmaceuticals Details
    • 2.5.2 Alnylam Pharmaceuticals Major Business
    • 2.5.3 Alnylam Pharmaceuticals Gene Delivery System Product and Solutions
    • 2.5.4 Alnylam Pharmaceuticals Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
  • 2.6 Amgen
    • 2.6.1 Amgen Details
    • 2.6.2 Amgen Major Business
    • 2.6.3 Amgen Gene Delivery System Product and Solutions
    • 2.6.4 Amgen Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Amgen Recent Developments and Future Plans
  • 2.7 Spark Therapeutics
    • 2.7.1 Spark Therapeutics Details
    • 2.7.2 Spark Therapeutics Major Business
    • 2.7.3 Spark Therapeutics Gene Delivery System Product and Solutions
    • 2.7.4 Spark Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Spark Therapeutics Recent Developments and Future Plans
  • 2.8 Akcea Therapeutics
    • 2.8.1 Akcea Therapeutics Details
    • 2.8.2 Akcea Therapeutics Major Business
    • 2.8.3 Akcea Therapeutics Gene Delivery System Product and Solutions
    • 2.8.4 Akcea Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Akcea Therapeutics Recent Developments and Future Plans
  • 2.9 bluebird bio
    • 2.9.1 bluebird bio Details
    • 2.9.2 bluebird bio Major Business
    • 2.9.3 bluebird bio Gene Delivery System Product and Solutions
    • 2.9.4 bluebird bio Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 bluebird bio Recent Developments and Future Plans
  • 2.10 Sunway Biotech
    • 2.10.1 Sunway Biotech Details
    • 2.10.2 Sunway Biotech Major Business
    • 2.10.3 Sunway Biotech Gene Delivery System Product and Solutions
    • 2.10.4 Sunway Biotech Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Sunway Biotech Recent Developments and Future Plans
  • 2.11 SIBIONO
    • 2.11.1 SIBIONO Details
    • 2.11.2 SIBIONO Major Business
    • 2.11.3 SIBIONO Gene Delivery System Product and Solutions
    • 2.11.4 SIBIONO Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 SIBIONO Recent Developments and Future Plans
  • 2.12 AnGes
    • 2.12.1 AnGes Details
    • 2.12.2 AnGes Major Business
    • 2.12.3 AnGes Gene Delivery System Product and Solutions
    • 2.12.4 AnGes Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 AnGes Recent Developments and Future Plans
  • 2.13 Orchard Therapeutics
    • 2.13.1 Orchard Therapeutics Details
    • 2.13.2 Orchard Therapeutics Major Business
    • 2.13.3 Orchard Therapeutics Gene Delivery System Product and Solutions
    • 2.13.4 Orchard Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Orchard Therapeutics Recent Developments and Future Plans
  • 2.14 Human Stem Cells Institute
    • 2.14.1 Human Stem Cells Institute Details
    • 2.14.2 Human Stem Cells Institute Major Business
    • 2.14.3 Human Stem Cells Institute Gene Delivery System Product and Solutions
    • 2.14.4 Human Stem Cells Institute Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Human Stem Cells Institute Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Gene Delivery System Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Gene Delivery System by Company Revenue
    • 3.2.2 Top 3 Gene Delivery System Players Market Share in 2022
    • 3.2.3 Top 6 Gene Delivery System Players Market Share in 2022
  • 3.3 Gene Delivery System Market: Overall Company Footprint Analysis
    • 3.3.1 Gene Delivery System Market: Region Footprint
    • 3.3.2 Gene Delivery System Market: Company Product Type Footprint
    • 3.3.3 Gene Delivery System Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Gene Delivery System Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Gene Delivery System Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Gene Delivery System Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Gene Delivery System Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Gene Delivery System Consumption Value by Type (2018-2029)
  • 6.2 North America Gene Delivery System Consumption Value by Application (2018-2029)
  • 6.3 North America Gene Delivery System Market Size by Country
    • 6.3.1 North America Gene Delivery System Consumption Value by Country (2018-2029)
    • 6.3.2 United States Gene Delivery System Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Gene Delivery System Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Gene Delivery System Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Gene Delivery System Consumption Value by Type (2018-2029)
  • 7.2 Europe Gene Delivery System Consumption Value by Application (2018-2029)
  • 7.3 Europe Gene Delivery System Market Size by Country
    • 7.3.1 Europe Gene Delivery System Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Gene Delivery System Market Size and Forecast (2018-2029)
    • 7.3.3 France Gene Delivery System Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Gene Delivery System Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Gene Delivery System Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Gene Delivery System Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene Delivery System Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Gene Delivery System Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Gene Delivery System Market Size by Region
    • 8.3.1 Asia-Pacific Gene Delivery System Consumption Value by Region (2018-2029)
    • 8.3.2 China Gene Delivery System Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Gene Delivery System Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Gene Delivery System Market Size and Forecast (2018-2029)
    • 8.3.5 India Gene Delivery System Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Gene Delivery System Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Gene Delivery System Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Gene Delivery System Consumption Value by Type (2018-2029)
  • 9.2 South America Gene Delivery System Consumption Value by Application (2018-2029)
  • 9.3 South America Gene Delivery System Market Size by Country
    • 9.3.1 South America Gene Delivery System Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Gene Delivery System Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Gene Delivery System Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene Delivery System Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Gene Delivery System Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Gene Delivery System Market Size by Country
    • 10.3.1 Middle East & Africa Gene Delivery System Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Gene Delivery System Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Gene Delivery System Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Gene Delivery System Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Gene Delivery System Market Drivers
  • 11.2 Gene Delivery System Market Restraints
  • 11.3 Gene Delivery System Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Gene Delivery System Industry Chain
  • 12.2 Gene Delivery System Upstream Analysis
  • 12.3 Gene Delivery System Midstream Analysis
  • 12.4 Gene Delivery System Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Gene Delivery System. Industry analysis & Market Report on Gene Delivery System is a syndicated market report, published as Global Gene Delivery System Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Gene Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,623.92
    3,935.88
    5,247.84
    3,121.56
    4,682.34
    6,243.12
    497,048.40
    745,572.60
    994,096.80
    291,136.80
    436,705.20
    582,273.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report